Healthcare provider profile · identity verified

Kenneth C Roberts, DO

Internal Medicine · BILOXY, MS · NPI 1194890848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	191	27
Eliquis	Apixaban	181	32
Atorvastatin Calcium	Atorvastatin Calcium	143	47
Furosemide	Furosemide	133	38
Pantoprazole Sodium	Pantoprazole Sodium	118	28
Amlodipine Besylate	Amlodipine Besylate	99	33
Potassium Chloride	Potassium Chloride	88	34
Tamsulosin Hcl	Tamsulosin Hcl	81	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	31
Gabapentin	Gabapentin	71	26
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	68	17
Donepezil Hcl	Donepezil Hcl	59	11
Losartan Potassium	Losartan Potassium	57	14
Clopidogrel	Clopidogrel Bisulfate	55	20
Lisinopril	Lisinopril	55	18
Trazodone Hcl	Trazodone Hcl	54	14
Metoprolol Tartrate	Metoprolol Tartrate	47	14
Famotidine	Famotidine	45	16
Omeprazole	Omeprazole	42	suppressed
Allopurinol	Allopurinol	40	11
Metoprolol Succinate	Metoprolol Succinate	40	13
Montelukast Sodium	Montelukast Sodium	38	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	18
Prednisone	Prednisone	35	25
Memantine Hcl	Memantine Hcl	34	suppressed
Midodrine Hcl	Midodrine Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Carvedilol	Carvedilol	32	19
Finasteride	Finasteride	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	11
Methocarbamol	Methocarbamol	28	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	26
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	14
Nystatin	Nystatin	26	12
Aripiprazole	Aripiprazole	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	13
Enulose	Lactulose	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Xtampza Er	Oxycodone Myristate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Nitroglycerin	Nitroglycerin	17	14
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	15	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Digoxin	Digoxin	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Metformin Hcl	Metformin Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Roflumilast	Roflumilast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error